urogen logo

UroGen is a clinical-stage specialty pharmaceutical company focused on developing innovative sustained release formulations for uro-oncology.

biopharmaceuticals
Public (NASDAQ: URGN)
Visit Website
Additional Portfolio Companies
Adicet Bio
ARTSaVIT
BioBlast Pharma
Cathworks
cCAM Biotherapeutics
CheckCap
Eloxx Pharmaceuticals
Enlivex Therapeutics
Entera Bio
Eyevensys
EyeYon
Hairstetics
Headsense
Keros Therapeutics
Kite Pharma
Leap Therapeutics
LogicBio Therapeutics
Metabomed
NovellusDX
Novus Therapeutics
Nutrinia
Ocon Medical
PACT Pharma
Pi Therapeutics
Protalix
Raziel Therapeutics
ReWalk
StimatixGI
Sweetch
TargEDys
UroGen
V-Wave
Zolex Therapeutics
July 12, 2015